Insights | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | April 18, 2025

Trump’s Drug Price Executive Order: What Drugmakers Should Know

Blog | November 25, 2024

New USPTO Patent Fees Go Into Effect January 19, 2025

Webinar | December 14, 2023

FTC Challenges to Orange Book Listings: Considerations for Patent Holders

Blog | December 13, 2023

Biden Administration Proposes March-In Rights Framework for Pharmaceutical Patents in Effort to Lower Drug Prices

Blog | November 09, 2023

FTC Challenges More Than 100 Patents as Improperly Listed in Orange Book

Webinar | August 09, 2023

Drafting Claims to Survive Hatch-Waxman Litigation

Article | October 20, 2022

Life Sciences Entrepreneur Sourcebook | Intellectual Property: What It Is and Why You Should Care

Blog | September 15, 2022

What to Know About the USPTO's Duty of Candor Guidance Regarding FDA Submissions

Webinar | July 20, 2022

Exploring Common Pitfalls of Privilege

Webinar | June 27, 2022

Medical and Digital Healthcare Inventions: The Inside Line in Europe and the U.S.

Article | February 01, 2022

Intellectual Property Do's and Don'ts for Early-Stage Life Sciences Companies

Webinar | September 14, 2021

Efficient and Effective IP Due Diligence